Table 2 Treatment response.
Treatment group | ALN* (n = 245) | MAS3** (n = 245) |
|---|---|---|
Compliance, no. (%) | ||
Completed day 7 | 241 (99.6%) | 240 (99.2%) |
Completed day 28 | 232 (95.9%) | 233 (96.3%) |
Completed day 42 | 225 (93.0%) | 227 (93.4%) |
Cumulative proportion of patients with clinical failure, no (%) | ||
Day 7 | 0 (0) | 0 (0) |
Day 28 | 13 (5.6) | 14 (6.0) |
Day 42 | 27 (12.0) | 24 (10.6) |
PCR, no. | ||
Novel | 23 | 14 |
Recrudescent | 2 | 8 |
Novel + recrudescent | 1 | 1 |
Indeterminate/missing | 1 | 1 |
PCR-adjusted cure rates, no. (%) | ||
Day 7 | 0 (100) | 0 (100) |
Day 28 | 2 (99.1) | 9(96.1) |
Day 42 | 3 (98.8) | 9 (96.3) |